Mark L. Fuerst

Rheumatology Network examines common comorbidities in rheumatoid arthritis and their role in limiting mobility.

Evaluating the cost of biologics for treating PsA: Adalimumab associated with highest costs, followed by Golimumab and Etanercept.

There is no compelling evidence that testosterone therapy increases or decreases cardiovascular risk, according to a new position statement from the American Academy of Clinical Endocrinologists (AACE).The statement was issued in response to recent publications that have raised concern that testosterone replacement therapy (TRT) increases cardiovascular risks in men and media reports about the dangers of testosterone therapy.

Repetitive intraarticular corticosteroid injections to the temporomandibular joint do not prevent progressive osseous deformation nor normalize mandibular growth in children with juvenile idiopathic arthritis.

Cardiac complications with diabetes and the effects of bariatric surgery on diabetes control are discussed in the following slides.

Ultrasound and fluorescence optical imaging can detect inflammation in hand joints of rheumatoid arthritis and osteoarthritis patients.

T cell activator associated with psoriatic arthritis but not psoriasis.

Atypical femur fractures could be more common in rheumatoid arthritis patients with valgus knee alignment undergoing long-term treatment with bisphosphonates, study shows.

Abatacept performs well in rheumatoid arthritis patients who are positive for anti-citrullinated protein antibodies.

Which GLP-1 receptor agonist induced weight loss in type 2 diabetes patients?

Researchers suggest vitamin D protects against cardiovascular disease and insulin resistance, but can they prove it?

Your patients can't hear this from you enough – exercise improves diabetes control.

The following slideshow covers findings of 3 recent studies on various complications associated with type 2 diabetes.

The majority of pregnant patients with systemic lupus erythematosus (SLE) have favorable pregnancy outcomes, with few experiencing severe flares.

Catch up on some of the latest headlines in diabetes care, including updates in pediatric management and an artificial pancreas.

The following studies highlight recent findings in fracture screening, fracture healing, and possible fracture prevention in T2DM patients.

Recent findings in thyroid cancer treatment, including laser ablation therapy, lenvatinib, and guidelines for treating pediatric patients, are shown in the following slides.

Exercise is one of the mainstays of diabetes treatment. Recent research shows that the higher the level of fitness, the lower the risk of an individual developing diabetes.

Ultrasound diagnosis of tenosynovitis has now been shown to be superior to clinical signs and symptoms (eg, early morning stiffness, symmetrical arthritis, and hand joint arthritis) in predicting early rheumatoid arthritis.

There is no generally accepted definition for remission of SLE. An international expert panel has provided a framework for testing individual definitions and issued 8 key statements regarding remission.

The availability of reliable, up-to-date information about biosimilars is crucial if patients are to understand these agents. A new position paper highlights what is needed to assist physicians, patient organizations, and patients.

The "Green Berets" of the brain, microglia cells, become hyperactive in fibromyalgia and are key to causing symptoms, said a psychologist and neuroscientist. Finding ways to control them is the key to future treatments, he feels.

At the American College of Physicians Internal Medicine Meeting 2015 in Boston, Peter Zimetbaum, MD, Associate Professor of Medicine, Harvard Medical School, presented an “Update In Cardiology.” Here are the highlights of his presentation and the implications for clinical practice.

Authors of a new study note that an observed link between antibiotics and diabetes risk may be yet another result of changing levels and diversity of gut bacteria.

Results of a new study are significant since asymptomatic, aggressive heart disease is the most common cause of death in patients with diabetes.

Clinical estimates of the incidence of diabetic nephropathy fall far short of the widespread presence of the disease suggested by a recent autopsy study.

A new study suggests that up to 1 in 5 patients with diabetes might be genetically programmed to derive little or no benefit from increased physical activity.

After sleeve gastrectomy, obese patients with type 2 DM who have less severe disease do better than those who have more advanced disease. Surgery should be encouraged sooner rather than later.

The need for diabetes and cardiac medications is reduced significantly in obese patients who undergo weight-loss surgery, and so are their costs.